News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Esposito Pamela
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 18,600 shares
@ $20.01, valued at
$372.2k
Exercised 13,600 options to buy
@ $3.3, valued at
$44.9k
Exercised 5,000 options to buy
@ $15.5, valued at
$77.5k
|
|
| 08/15/2023 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 1,400 shares
@ $20, valued at
$28k
Exercised 1,400 options to buy
@ $3.3, valued at
$4.6k
|
|
| 07/11/2023 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 17,923 shares
@ $21.63, valued at
$387.7k
Sold 2,077 shares
@ $21.12, valued at
$43.9k
Exercised 15,000 options to buy
@ $3.3, valued at
$49.5k
Exercised 5,000 options to buy
@ $15.5, valued at
$77.5k
|
|
| 05/18/2023 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 5,966 shares
@ $18.05, valued at
$107.7k
|
|
| 04/04/2023 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 60,000 options to buy
@ $17.66, valued at
$1.1M
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Esposito Pamela (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $14.18, valued at
$170.2k
|
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 22,750 shares
@ $0
Granted 34,125 options to buy
@ $18.26, valued at
$623.1k
|
|
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 4,600 shares
@ $33.37, valued at
$153.5k
Exercised 4,600 options to buy
@ $1.01, valued at
$4.6k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Exercised 50,704 options to buy
@ $1.75, valued at
$88.7k
|
|
| 12/15/2020 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Exercised 12,590 options to buy
@ $3.3, valued at
$41.5k
|
|
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2020 |
4
| Esposito Pamela (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 40,127 options to buy
@ $29.55, valued at
$1.2M
|
|
| 09/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2020 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 85,450 options to buy
@ $9.78, valued at
$835.7k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 75,750 options to buy
@ $15.5, valued at
$1.2M
|
|
| 12/17/2018 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Exercised 87,000 options to buy
@ $1.75, valued at
$152.3k
|
|
| 07/26/2018 |
4
| Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 70,000 options to buy
@ $15, valued at
$1.1M
|
|
|
|